Literature DB >> 6462625

Conjunctival melanosis and melanoma.

R Folberg, I W McLean, L E Zimmerman.   

Abstract

A clinicopathologic study of 41 cases of primary acquired melanosis has provided information concerning the rate of progression to melanoma and has provided histologic parameters useful in predicting which lesions are likely to progress to malignant melanoma. A clinicopathologic study of 131 conjunctival melanomas has provided information concerning the clinical and histologic parameters associated with a fatal outcome. Highlights of these two studies are presented together with implications for diagnosis and therapy.

Entities:  

Mesh:

Year:  1984        PMID: 6462625     DOI: 10.1016/s0161-6420(84)34245-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C.

Authors:  Carol L Shields; Hakan Demirci; Jerry A Shields; Christopher Spanich
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.

Authors:  S Seregard
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

3.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

4.  Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population.

Authors:  J C Norregaard; N Gerner; O A Jensen; J U Prause
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

5.  In vivo confocal microscopy of pigmented conjunctival tumors.

Authors:  Elisabeth M Messmer; Marc J Mackert; Daniel M Zapp; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-06       Impact factor: 3.117

6.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

7.  Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.

Authors:  P De Potter; C L Shields; J A Shields; H Menduke
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

8.  MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia.

Authors:  I Chowers; N Livni; A Solomon; G Zajicek; J Frucht-Pery; R Folberg; J Pe'er
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

Review 9.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 10.  The ultrastructure of conjunctival melanocytic tumors.

Authors:  F A Jakobiec
Journal:  Trans Am Ophthalmol Soc       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.